XBI Biotech sector
Company Analysis
Latest News
Biotech Sector Surges on Continued M&A Momentum
The biotech sector, proxied by the XBI ETF, is trading higher today, continuing a period of strong performance driven by a robust environment for mergers and...
🔴 XBI is trading 3% down today amid a broader risk-off pullback in biotech and tech
XBI is trading 3% down at $151.50 as biotech stocks slide alongside a sharper tech and AI-led sell-off. • Investors are trimming exposure to higher-risk...
Biotech Stocks Decline Amid Broader Market Tech Sell-Off
The biotech sector, as measured by the XBI ETF, fell 2.00% in the current session, mirroring a wider market downturn led by a sell-off in technology and...
🔴 XBI is trading 3.32% down today on broader biotech sector pressure and profit-taking
XBI is trading 3.32% down at $158.82 amid broader biotech sector pressure and a shift toward softer risk sentiment. • The decline follows a weak open for...
🟢 XBI is trading 3.1% up today amid sector momentum, spurred by major M&A activity in the biotech sector, and a rising borrow rate
• XBI is trading 3.1% up at $154.35 following strong momentum in the biotechnology sector. • This rally is notably bolstered by Merck KGaA's $11.3 billion cash...
🟢 XBI is trading 3.01% up today as multi-day biotech rally extends
XBI is trading at +3.01% now at $151.46 after extending a multi-day biotech rally. • The move is driven by broader biotechnology sector momentum and a...
🟢 XBI is trading 3.7% up today as biotech rally extends
XBI is trading 3.7% up at $145.76 in pre-market, extending a strong multi-day rally in biotech names. • The move appears driven by continued sector momentum...